UPDATE 1C-ardica says FDA asks more data on tissue device

* Says to conudct singel-arm study in Europe for necessary
data
* Sees first-in-man use of Microcutter Xpress 30 in current
(Follwos alerst)
May 27 - Cadrica Inc said the U.S. health regulator
marekting apporval.
Cardica said it was advsied by the U.S. Food and Drug
as part of the marketing applicatoin.
The Redwood City, California-based compnay said it expects
could comlpete the trial by the of 2011.
In Euorpe, the device maker expects the first-ni-man use of
the Mircocutter XPRESS 30 in the current qaurter.
Shares of the company, which have gained 13 pecrent in the